Jul 2026· Journal of Immunology· Vol 215· 0 citations
TL;DR
A 61-parameter CyTOF panel for in-depth functional immune profiling of human PBMC is designed, revealing striking cross-lineage immuno-functional diversity at the single-cell level.
Abstract
High-parameter cytometric analysis enables discoveries of potential therapeutic targets and informs disease prognoses in translational and clinical research. CyTOF™ technology is a single-cell analysis platform that uses metal-tagged antibodies to resolve 50-plus markers in a single tube. Notably, antibody cocktails and stained samples can be frozen for later use and acquisition, or barcoded and pooled together, minimizing technical variation. Unlike fluorescence-based cytometry, spectral unmixing and single-stain controls are not required. Therefore, it is uniquely possible with CyTOF technology to rapidly design high-parameter panels and use intracellular markers to gain functional insights. The goal of this study was to design a 61-parameter CyTOF panel for in-depth functional immune profiling of human PBMC.
The panel contains lineage markers for major immune cell subsets and a diverse array of phenotyping T cell targets focused on activation, differentiation, checkpoint and cytokines and can be used to identify over 60 cell populations. Untreated and stimulated PBMC were barcoded, pooled and stained. Samples were frozen and acquired on a later day using a CyTOF XT PRO system.
High-dimensional analysis of stimulated PBMC revealed striking cross-lineage immuno-functional diversity at the single-cell level. The expression of over 20 markers spanning the functional landscape of activation, checkpoints and cytokines was revealed across effector, memory, cytotoxic, regulatory and exhausted immune cell populations.
CyTOF systems enable the highest number of simultaneous measurements in a single panel, allowing for wide immune coverage and high resolution of intracellular targets to interrogate functional potential. Overall, studying functional immunology using CyTOF technology can elucidate the complex nature of immune responses to provide an understanding of how they relate to disease and treatments.
For Research Use Only. Not for use in diagnostic procedures.,
n/a
Immune Mechanisms of Human Disease (HUM)
Peripheral blood mononuclear cells (PBMCs) are commonly used for immune profiling in clinical research, but their isolation and cryopreservation present logistical challenges, particularly in settings with limited access to research facilities. To address this, we implemented a whole blood fixation protocol to preserve...
V. Parthasarathy, A. Heubeck, Tyanna J. Stuckey et al.· Cytometry Part A· 0 citations
The identification of novel compounds capable of stimulating or suppressing immune responses is critical for advancing immunotherapy and improving our understanding of immune regulation. However, traditional screening approaches are often limited by low throughput, poor physiological relevance, and insufficient resolut...
Regine Brox, Holger Hackstein· Journal of Immunological Res...· 0 citations
Introduction Systemic lupus erythematosus (SLE) and other chronic inflammatory diseases are complex, multifactorial conditions where patient heterogeneity poses a major challenge to treatment. Despite the availability of numerous omics technologies, reliable biomarkers for precision medicine remain scarce, and many cel...
M. Burns, Lennard Ostendorf, Amro Abbas et al.· Frontiers in Immunology· 0 citations
Comprehensive immune profiling is essential for immunomonitoring studies aimed at identification of diagnostic and prognostic biomarkers. Peripheral blood mononuclear cells (PBMCs) undergo phenotypic and functional changes during disease, making them invaluable for the characterization of immune cell composition in bot...
M. H. Rietdijk, Leo C. Kuhnen, M. van den Braber et al.· Frontiers in Immunology· 0 citations
Introduction Pancreatic cancer (PC) remains an aggressive malignancy with poor clinical outcomes, underscoring the need for novel biomarkers to monitor patients. Immune checkpoint molecules [programmed death ligand 1 (PD-L1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)] have been detected in CTCs, and their...
Chrysoula Tagari, Karolina Mangani, Michael Gogolides et al.· Frontiers in Cell and Develo...· 0 citations